Topiramate for Alcohol Use in Posttraumatic Stress Disorder
Status:
Terminated
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
Alcohol abuse and dependence (alcohol use disorders, AUDs) and posttraumatic stress disorder
(PTSD) are both prevalent in Veterans. Treating AUDs in Veterans with PTSD may be more
difficult than treating AUDs in the general population. The FDA-approved medication
topiramate has been shown to improve drinking outcomes in people with AUDs. Topiramate has
also improved symptoms in people with PTSD. This study is designed to investigate whether
topiramate will improve drinking outcomes in Veterans with PTSD.
Phase:
N/A
Details
Lead Sponsor:
University of Maryland University of Maryland, Baltimore
Collaborators:
US Department of Veterans Affairs VA Office of Research and Development